ArticleFrontiers in immunology2019
Therapeutic Protection Against
Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 34 citations in OpenAlex.
- Review
- Development of a Mucosal Immune-Enhancing Oral Vaccine Candidate Against Porcine Epidemic Diarrhea Virus UsingAnimals : an open access journal from MDPI · 2026Article
- Towards EffectiveInternational journal of molecular sciences · 2025Review
- Construction and evaluation of aFrontiers in immunology · 2025Article
- A critical review onFrontiers in cellular and infection microbiology · 2025Review
- Review
- Developing a potent vaccine againstExpert reviews in molecular medicine · 2024Review
- An M cell-targeting recombinant L. lactis vaccine against four H. pylori adhesins.Applied microbiology and biotechnology · 2024Article
- Novel therapeutic regimens againstFrontiers in microbiology · 2024Review
- Pivotal role ofFrontiers in medicine · 2024Review
- Review
- How Long Will It Take to Launch an EffectiveInfection and drug resistance · 2023Review
- Review
- The Role ofInternational journal of molecular sciences · 2022Review
- Oral Administration of aFrontiers in immunology · 2022Article
- Detection and Treatment ofGastroenterology research and practice · 2022Review
- Oral Immunization With a M Cell-Targeting RecombinantFrontiers in immunology · 2022Article
- Identification of B-Cell Epitopes of HspA fromVaccines · 2021Article
- Self-assembled aggregations inChinese herbal medicines · 2021Article
- Hydrogen Peroxide-Mediated Oxygen Enrichment Eradicates Helicobacter pyloriAntimicrobial agents and chemotherapy · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urease is an effective target for design of a therapeutic epitope vaccine against
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.